semaglutide and tirzepatide Comparative safety side effects of and tirzepatide: Implications for clinical decision-making in obesity management The GLP-1 Solution: 175+ Strategies,

Data availability Data will be shared with bona fide researchers submitting a research proposal approved by the independent review board

If the prescriber writes a prescription with a diagnosis outside the ForwardHealth-allowed diagnoses for a drug, the prescriber is required to include peer-reviewed medical literature to support the proven efficacy and safety of the requested use of the drug

Available evidence suggests retatrutide may drive substantial fat-mass reduction, and a recent body-composition substudy reported that the proportion of lean-mass loss relative to total weight loss was similar to other obesity treatments

Phentermine vs GLP-1 comparisons reveal significant differences in safety, efficacy, and duration of use